Clene Nanomedicine - Latest News and Information
Technology Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
CLNN
Clene Nanomedicine is a clinical-stage biopharmaceutical company focused on developing nanotherapeutics to treat neurodegenerative diseases by restoring and protecting neuronal energy and function. The company leverages Clean-Surface Nanocrystal (CSN) technology, CNM-Au8, to address cellular energy impairments across CNS disorders. Headquartered in Salt Lake City, Utah, with manufacturing and R&D operations in North East, Maryland, Clene aims to advance a pipeline of nanomedicine therapies for high unmet medical needs in neurology.
No recent news for this company.
